Thanks for the response, but can you explain how Jeffreies can assign a 60% probability of success in the succeed trial and still report that the drug will more likely miss its primary endpoint?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.